Patent details

EP3691643 Title: COMBINATION OF THE IDO INHIBITOR LINRODOSTAT WITH THE PD-1 INHIBITOR NIVOLUMAB TO TREAT BLADDER CANCER

Basic Information

Publication number:
EP3691643
PCT Application Number:
US2018053443
Type:
European Patent Granted for LU
Legal Status:
In force
Application number:
EP188615983
PCT Publication Number:
WO2019067913
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
COMBINATION OF THE IDO INHIBITOR LINRODOSTAT WITH THE PD-1 INHIBITOR NIVOLUMAB TO TREAT BLADDER CANCER
French Title of Invention:
COMBINATION DE L'INHIBITEUR D'IDO LINRODOSTAT AVEC L'INHIBITEUR DE PD-1 NIVOLUMAB POUR LE TRAITEMENT DU CANCER DE LA VESSIE
German Title of Invention:
KOMBINATION DES IDO-INHIBITORS LINRODOSTAT MIT DEM PD-1 INHIBITOR NIVOLUMAB ZUR BEHANDLUNG VON BLASENKREBS
SPC Number:

Dates

Filing date:
28/09/2018
Grant date:
27/05/2026
EP Publication Date:
12/08/2020
PCT Publication Date:
04/04/2019
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
27/05/2026
EP B1 Publication Date:
27/05/2026
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
Expiration date:
28/09/2038
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
20/05/2026
 
 

Name:
Bristol-Myers Squibb Company
Address:
Route 206 and Province Line Road, Princeton, NJ 08543, United States (US)

Inventor

1

Name:
AZRILEVICH, Alexander
Address:
United States (US)

2

Name:
BERNSTEIN, Steven H.
Address:
United States (US)

3

Name:
WALKER, Justine Kamilah
Address:
United States (US)

4

Name:
SIMONSEN, Katy Lynn
Address:
United States (US)

5

Name:
PHILLIPS, Penny E.
Address:
United States (US)

6

Name:
BASCIANO, Paul Andrew
Address:
United States (US)

7

Name:
SRIVASTAVA, Shivani
Address:
United States (US)

8

Name:
CASSIDY, James
Address:
United States (US)

9

Name:
ZHU, Li
Address:
United States (US)

Priority

1

Priority Number:
201762565819 P
Priority Date:
29/09/2017
Priority Country:
United States (US)

2

Priority Number:
201762569766 P
Priority Date:
09/10/2017
Priority Country:
United States (US)

3

Priority Number:
201762580219 P
Priority Date:
01/11/2017
Priority Country:
United States (US)

4

Priority Number:
201762609210 P
Priority Date:
21/12/2017
Priority Country:
United States (US)

5

Priority Number:
201862642711 P
Priority Date:
14/03/2018
Priority Country:
United States (US)

6

Priority Number:
201862678490 P
Priority Date:
31/05/2018
Priority Country:
United States (US)

Classification

IPC classification:
A61K 31/47; A61P 13/12; A61K 45/06; A61K 39/00; A61P 35/00;

Publication

European Patent Bulletin

Issue number:
202622
Publication date:
27/05/2026
Description:
Grant (B1)

Annual Fees

Annual Fee Due Date:
30/09/2026
Annual Fee Number:
9
Annual Fee Amount:
115 Euro
Expected Payer:
Last Annual Fee Payment Date:
Last Annual Fee Paid Number:
Payer:
Filing date Document type Number of pages